Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injury.

MLA

Wang, Yilan, et al. “Notoginsenoside R1 Treatment Facilitated Nrf2 Nuclear Translocation to Suppress Ferroptosis via Keap1/Nrf2 Signaling Pathway to Alleviated High-Altitude Myocardial Injury.” Biomedicine & Pharmacotherapy, vol. 175, June 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.biopha.2024.116793.

APA

Wang, Y., Yin, Y., Liu, Y., Pei, C., Shen, Z., Zhao, S., Jia, N., Huang, D., Wang, X., Wu, Y., Shi, S., He, Y., & Wang, Z. (2024). Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injury. Biomedicine & Pharmacotherapy, 175, N.PAG. https://doi.org/10.1016/j.biopha.2024.116793

Chicago

Wang, Yilan, Yongjun Yin, Ying Liu, Caixia Pei, Zherui Shen, Sijing Zhao, Nan Jia, et al. 2024. “Notoginsenoside R1 Treatment Facilitated Nrf2 Nuclear Translocation to Suppress Ferroptosis via Keap1/Nrf2 Signaling Pathway to Alleviated High-Altitude Myocardial Injury.” Biomedicine & Pharmacotherapy 175 (June): N.PAG. doi:10.1016/j.biopha.2024.116793.